These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
127 related articles for article (PubMed ID: 1324678)
21. Substrate dependence of angiotensin I-converting enzyme inhibition: captopril displays a partial selectivity for inhibition of N-acetyl-seryl-aspartyl-lysyl-proline hydrolysis compared with that of angiotensin I. Michaud A; Williams TA; Chauvet MT; Corvol P Mol Pharmacol; 1997 Jun; 51(6):1070-6. PubMed ID: 9187274 [TBL] [Abstract][Full Text] [Related]
22. A deeply recessed active site in angiotensin-converting enzyme is indicated from the binding characteristics of biotin-spacer-inhibitor reagents. Bernstein KE; Welsh SL; Inman JK Biochem Biophys Res Commun; 1990 Feb; 167(1):310-6. PubMed ID: 2155615 [TBL] [Abstract][Full Text] [Related]
23. Selective inhibition of the C-domain of angiotensin I converting enzyme by bradykinin potentiating peptides. Cotton J; Hayashi MA; Cuniasse P; Vazeux G; Ianzer D; De Camargo AC; Dive V Biochemistry; 2002 May; 41(19):6065-71. PubMed ID: 11994001 [TBL] [Abstract][Full Text] [Related]
24. [Study of substrate specificity of a new peptide substrate of endothelin converting enzyme]. Gureeva TA; Kugaevskaia EV; Pozdnev VF; Prozorovskiĭ VN; Eliseeva IuE; Solov'eva NI Biomed Khim; 2007; 53(2):172-80. PubMed ID: 17639718 [TBL] [Abstract][Full Text] [Related]
25. [Determination of angiotensin-converting enzyme activity using dansyl-Phe-Ala-Arg as the substrate]. Shchetinina NV; Vernigora AN; Gengin MT Ukr Biokhim Zh (1999); 2001; 73(5):119-22. PubMed ID: 12035495 [TBL] [Abstract][Full Text] [Related]
26. Surface plasmon resonance analysis of the binding mechanism of pharmacological and peptidic inhibitors to human somatic angiotensin I-converting enzyme. Zidane F; Zeder-Lutz G; Altschuh D; Girardet JM; Miclo L; Corbier C; Cakir-Kiefer C Biochemistry; 2013 Dec; 52(48):8722-31. PubMed ID: 24168709 [TBL] [Abstract][Full Text] [Related]
28. A calorimetric study of the binding of lisinopril, enalaprilat and captopril to angiotensin-converting enzyme. Andújar-Sánchez M; Cámara-Artigas A; Jara-Pérez V Biophys Chem; 2004 Oct; 111(2):183-9. PubMed ID: 15381315 [TBL] [Abstract][Full Text] [Related]
29. Angiotensin converting enzyme inhibition in plasma and tissues. Johnston CI; Cubela R; Sakaguchi K; Jackson B Clin Exp Hypertens A; 1987; 9(2-3):307-21. PubMed ID: 3038391 [TBL] [Abstract][Full Text] [Related]
30. The influence of angiotensin converting enzyme mutations on the kinetics and dynamics of N-domain selective inhibition. Lubbe L; Sewell BT; Sturrock ED FEBS J; 2016 Nov; 283(21):3941-3961. PubMed ID: 27636235 [TBL] [Abstract][Full Text] [Related]
31. Pharmacodynamic effects of C-domain-specific ACE inhibitors on the renin-angiotensin system in myocardial infarcted rats. Sharp S; Poglitsch M; Zilla P; Davies NH; Sturrock ED J Renin Angiotensin Aldosterone Syst; 2015 Dec; 16(4):1149-58. PubMed ID: 25757657 [TBL] [Abstract][Full Text] [Related]
32. Variation in angiotensin-converting enzyme (ACE) inhibitor affinity at two binding sites on rat pulmonary ACE: influence on bradykinin hydrolysis. Perich RB; Jackson B; Johnston CI Clin Exp Pharmacol Physiol; 1992 May; 19(5):353-7. PubMed ID: 1325885 [TBL] [Abstract][Full Text] [Related]
33. Antioxidant peptides with Angiotensin converting enzyme inhibitory activities and applications for Angiotensin converting enzyme purification. Hou WC; Chen HJ; Lin YH J Agric Food Chem; 2003 Mar; 51(6):1706-9. PubMed ID: 12617609 [TBL] [Abstract][Full Text] [Related]
35. Converting-enzyme inhibitors increase converting-enzyme mRNA and activity in endothelial cells. King SJ; Oparil S Am J Physiol; 1992 Oct; 263(4 Pt 1):C743-9. PubMed ID: 1329541 [TBL] [Abstract][Full Text] [Related]
36. In silico identification of milk antihypertensive di- and tripeptides involved in angiotensin I-converting enzyme inhibitory activity. Vukic VR; Vukic DV; Milanovic SD; Ilicic MD; Kanuric KG; Johnson MS Nutr Res; 2017 Oct; 46():22-30. PubMed ID: 29173648 [TBL] [Abstract][Full Text] [Related]
37. A comparison of the zinc contents and substrate specificities of the endothelial and testicular forms of porcine angiotensin converting enzyme and the preparation of isoenzyme-specific antisera. Williams TA; Barnes K; Kenny AJ; Turner AJ; Hooper NM Biochem J; 1992 Dec; 288 ( Pt 3)(Pt 3):875-81. PubMed ID: 1335236 [TBL] [Abstract][Full Text] [Related]
38. Purification of angiotensin-converting enzyme from rabbit lung and human plasma by affinity chromatography. Bull HG; Thornberry NA; Cordes EH J Biol Chem; 1985 Mar; 260(5):2963-72. PubMed ID: 2982846 [TBL] [Abstract][Full Text] [Related]
39. Mapping the active site of angiotensin-converting enzyme by transferred NOE spectroscopy. Mayer M; Meyer B J Med Chem; 2000 Jun; 43(11):2093-9. PubMed ID: 10841788 [TBL] [Abstract][Full Text] [Related]
40. Apparent kinetics of angiotensin converting enzyme: hydrolysis of [3H]benzoyl-phenylalanyl-alanyl-proline in the isolated perfused lung. Ashton JH; Pitt BR; Gillis CN J Pharmacol Exp Ther; 1985 Mar; 232(3):602-7. PubMed ID: 2983065 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]